NO874704L - Minaktivin fremstilt ved rekombinant dna-teknikk. - Google Patents

Minaktivin fremstilt ved rekombinant dna-teknikk.

Info

Publication number
NO874704L
NO874704L NO87874704A NO874704A NO874704L NO 874704 L NO874704 L NO 874704L NO 87874704 A NO87874704 A NO 87874704A NO 874704 A NO874704 A NO 874704A NO 874704 L NO874704 L NO 874704L
Authority
NO
Norway
Prior art keywords
minactivin
recombinant dna
dna technology
manufactured
purification
Prior art date
Application number
NO87874704A
Other languages
English (en)
Other versions
NO178504B (no
NO874704D0 (no
NO178504C (no
Inventor
Toni Marie Antalis
Michael Thomas Barnes
Michelle Alison Clarke
Peter Leonard Devine
Neil Howard Goss
Philip Ralph Lehrbach
Original Assignee
Biotech Australia Pty Ltd
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd, Univ Australian filed Critical Biotech Australia Pty Ltd
Publication of NO874704D0 publication Critical patent/NO874704D0/no
Publication of NO874704L publication Critical patent/NO874704L/no
Priority to NO952506A priority Critical patent/NO952506D0/no
Publication of NO178504B publication Critical patent/NO178504B/no
Publication of NO178504C publication Critical patent/NO178504C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8132—Plasminogen activator inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9723—Urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
NO874704A 1986-03-13 1987-11-11 Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat NO178504C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO952506A NO952506D0 (no) 1986-03-13 1995-06-22 Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPH501786 1986-03-13
AUPH603386 1986-05-22
AUPH810086 1986-09-18
AUPH910486 1986-11-21
PCT/AU1987/000068 WO1987005628A1 (en) 1986-03-13 1987-03-13 Minactivin produced by recombinant dna technology

Publications (4)

Publication Number Publication Date
NO874704D0 NO874704D0 (no) 1987-11-11
NO874704L true NO874704L (no) 1987-11-11
NO178504B NO178504B (no) 1996-01-02
NO178504C NO178504C (no) 1996-04-10

Family

ID=27424177

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874704A NO178504C (no) 1986-03-13 1987-11-11 Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat

Country Status (13)

Country Link
US (1) US5426044A (no)
EP (1) EP0238275B1 (no)
JP (2) JP2589996B2 (no)
KR (1) KR960001820B1 (no)
CN (2) CN1032019C (no)
AT (1) ATE132192T1 (no)
CA (1) CA1338381C (no)
DE (1) DE3751646T2 (no)
DK (2) DK172400B1 (no)
IL (1) IL81879A (no)
NO (1) NO178504C (no)
NZ (1) NZ219608A (no)
WO (1) WO1987005628A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
DK0446315T3 (da) * 1989-09-05 1998-01-05 Biotech Australia Pty Ltd Fremgangsmåde til fremstilling af PAI-2
AU625018B2 (en) * 1989-12-20 1992-06-25 Biotech Australia Pty Limited Variants of pai-2
GB9026737D0 (en) * 1990-12-08 1991-01-30 Delta Biotechnology Ltd Cancer treatment
US5994309A (en) 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
CN102586187A (zh) * 2012-02-23 2012-07-18 深圳市中美康士生物科技有限公司 一种中性粒细胞体外保存方法及培养基

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
JPH0655152B2 (ja) * 1984-08-13 1994-07-27 バイオテクノロジー・オーストラリア・ピーテイーワイ・リミテツド ミナクチビンの製造方法
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation

Also Published As

Publication number Publication date
EP0238275B1 (en) 1995-12-27
ATE132192T1 (de) 1996-01-15
CA1338381C (en) 1996-06-11
KR960001820B1 (ko) 1996-02-05
DE3751646T2 (de) 1996-10-17
DK595187D0 (da) 1987-11-13
WO1987005628A1 (en) 1987-09-24
JP2660681B2 (ja) 1997-10-08
DK27097A (da) 1997-03-13
CN87102725A (zh) 1987-11-11
NO178504B (no) 1996-01-02
US5426044A (en) 1995-06-20
EP0238275A3 (en) 1989-05-10
JPH08112094A (ja) 1996-05-07
DK595187A (da) 1988-07-21
DE3751646D1 (de) 1996-02-08
NO874704D0 (no) 1987-11-11
CN1100957A (zh) 1995-04-05
NZ219608A (en) 1991-05-28
IL81879A (en) 1994-07-31
NO178504C (no) 1996-04-10
CN1032019C (zh) 1996-06-12
EP0238275A2 (en) 1987-09-23
JPS63503354A (ja) 1988-12-08
JP2589996B2 (ja) 1997-03-12
KR880701073A (ko) 1988-07-25
DK172400B1 (da) 1998-05-18

Similar Documents

Publication Publication Date Title
FI100056B (fi) Ihmisproapolipoproteiinin A-I ilmaiseminen
RU95115239A (ru) Аналог эритропоэтина
FI953658A0 (fi) Stabiileja bakterisidisia/läpäisevyyttä parantavia proteiinituotteita ja näitä sisältäviä farmaseuttisia koostumuksia
DE3650540D1 (de) Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
NO875136D0 (no) Heste - gamma - interferon.
DE3751269D1 (de) Expression des biologisch aktiven Faktors XIII.
ATE338113T1 (de) Transferrin-rezeptor gene von haemophilus
DE69737766D1 (de) Zusammensetzungen von stammzellfaktor (scf)-analogen und auf diese bezogene verfahren
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
DE59108947D1 (de) Neues menschliches, rekombinantes interferon gamma
NO930428L (no) Proteinstrukturen til plantetoksingelonin
EP0261403A3 (de) Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle
ES2124694T3 (es) Clonacion de la n-metil-hidantoinasa.
DE602004019556D1 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon
DK210288A (da) Overproduktion af exocelllulaere proteiner
TH5997EX (th) การสร้างโปรอโปดิโปรโปรตีน a-i ของคนโดยการแสดงออกของรหัสพันธุกรรม

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2002